SCHEMBL1395400

SCHEMBL1395400

CON(C)C(=O)C(Cc1ccc(Br)cc1)c1cccc(C)c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.45
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
TDP1 Q9NUW8 1/20 0.40
AOC3 Q16853 1/20 0.38
ACHE P22303 1/20 0.38
CACNA1G O43497 1/20 0.37
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PTGFR P43088 3/20 0.36
CHRM1 P11229 1/20 0.36
OPRM1 P35372 1/20 0.36
OPRD1 P41143 1/20 0.36
STAT3 P40763 1/20 0.36
HDAC1 Q13547 2/20 0.35
HDAC6 Q9UBN7 2/20 0.35
THRA P10827 1/20 0.35
THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1395396 1.00 FAAH (0.45) FAAHMEN1KMT2ATDP1AOC3
SCHEMBL370420 0.81 PTGFR (0.47) MEN1KMT2AALDH1A1LMNASMN1; SMN2
SCHEMBL1152868 0.79 FAAH (0.51) FAAHMEN1KMT2ATDP1ALDH1A1
SCHEMBL369643 0.77 RAB9A (0.45) MEN1KMT2ATDP1ALDH1A1LMNA
SCHEMBL3522126 0.75 OPRL1 (0.47) FAAHMEN1KMT2AAOC3ALDH1A1
SCHEMBL369940 0.75 LMNA (0.46) MEN1KMT2AALDH1A1LMNASMN1; SMN2
SCHEMBL13968362 0.74 FAAH (0.56) FAAHMEN1KMT2ATDP1ALDH1A1
SCHEMBL3370193 0.74 FAAH (0.50) FAAHTDP1ALDH1A1LMNACHRM1
SCHEMBL1395399 0.69 FFAR1 (0.35) ALDH1A1LMNASMN1; SMN2PTGFR
SCHEMBL1395269 0.68 MAPT (0.39) MEN1KMT2AALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 FAAH 1160/4885MEN1 1315/4885KMT2A 3981/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.